510(k) device
Caddie
Odin Medical Limited · Gastrointesinal Lesion Software Detection System (QNP, Class II) · First FDA decision Jul 24, 2024, newest Sep 12, 2026Colorectal cancer and polyps
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
3
Naming "Caddie"
MAUDE reports
0
Brand "Caddie", since 2015
PubMed studies
21
Mentioning "Caddie"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Caddie
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- CADDIE510(k)
K260133 · Decided Sep 12, 2026 · 239 days after receipt
Device type: Gastrointesinal Lesion Software Detection System (QNP) · GI, Urology & Nephrology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Caddie", any status and sponsor, newest update first.
- EAGLE Trial CADDIE Artificial Intelligence EndoscopyPivotal-lookingCompleted
Odin MedicalNot on our public-company list
NCT05730192 · 985 participants · Start May 10, 2023 · Primary completion Nov 20, 2023
Device: Colonoscopy with CADDIE · For: Colorectal Cancer; Polyp of Colon; Adenoma Colon
Sites: Berlin, Germany; Castellanza, Italy; Catania, Italy · 8 sites in all
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Caddie", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QNP
2 reports: 2 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Caddie"[tiab]. The summary above synthesizes these.
- Cancer driver drug interaction explorer.
Hartung M, Anastasi E, Mamdouh ZM, et al. · Nucleic Acids Res · 2022Research Support, Non-U.S. Gov't
- FEASIBILITY AND SAFETY OF A FIELD CARE CLINIC AS AN ALTERNATIVE AMBULANCE DESTINATION DURING THE COVID-19 PANDEMIC.
Berger D, Wong-Castillo J, Seymour R, et al. · Int J Paramed · 2023
- The Crystal Structure of Tyrosinase from Verrucomicrobium spinosum Reveals It to Be an Atypical Bacterial Tyrosinase.
Fekry M, Dave KK, Badgujar D, et al. · Biomolecules · 2023
- Effects of Ground Slopes on Erector Spinae Muscle Activities and Characteristics of Golf Swing.
Li B, Wang J, Wu C, et al. · Int J Environ Res Public Health · 2023
- Activation Mechanism of the Streptomyces Tyrosinase Assisted by the Caddie Protein.
Matoba Y, Kihara S, Muraki Y, et al. · Biochemistry · 2017Research Support, Non-U.S. Gov't
- Structural and mechanistic insights into the oxy form of tyrosinase from molecular dynamics simulations.
Deeth RJ, Diedrich C · J Biol Inorg Chem · 2010Research Support, Non-U.S. Gov't
- Tat-Dependent Heterologous Secretion of Recombinant Tyrosinase by Pseudomonas fluorescens Is Aided by a Translationally Fused Caddie Protein.
Ryu J, Byun H, Park JP, et al. · Appl Environ Microbiol · 2019Research Support, Non-U.S. Gov't
- A molecular mechanism for copper transportation to tyrosinase that is assisted by a metallochaperone, caddie protein.
Matoba Y, Bando N, Oda K, et al. · J Biol Chem · 2011Research Support, Non-U.S. Gov't
- Effect of slope change on kinematics of amateur golfers' full swing.
Li B, Li H, Tang X, et al. · Technol Health Care · 2023
- Unveiling the Molecular Landscape of FOXA1 Mutant Prostate Cancer: Insights and Prospects for Targeted Therapeutic Strategies.
Hwang KW, Yun JW, Kim HS · Int J Mol Sci · 2023
- The basicity of an active-site water molecule discriminates between tyrosinase and catechol oxidase activity.
Matoba Y, Oda K, Muraki Y, et al. · Int J Biol Macromol · 2021
- Returning persons with SARS-CoV-2 to the field of play in professional golf: a risk assessment and risk reduction approach.
Robinson PG, Murray A, Close G, et al. · BMJ Open Sport Exerc Med · 2022
Other devices of this type
Also filed under product code QNP.
- SKOUT® systemIterative Scopes, Inc. · 510(k) 2024
- GI Genius Module 300 (GGM300-US)Cosmo Artificial Intelligence - Ai, Ltd. · 510(k) 2026
- Magentiq-Colo (Me-Apds)Magentiq Eye, Ltd. · 510(k) 2026
- GI Genius System 100 and GI Genius System 200Cosmo Artificial Intelligence - Ai, Ltd. · De Novo 2023
- EW10-EC02 Endoscopy Support ProgramFujifilm Corporation · 510(k) 2026
- SKOUT systemIterative Health · 510(k) 2025
- CAD - Lower GI (EC07-01)Xiamen Inno Medical Technology Co., Ltd. · 510(k) 2026
- Me-ApdsMagentiq Eye, Ltd. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.